BRACCO, General Electric Company, Guerbet and many others are Dominating the market for Global Contrast and Imaging Agents in Interventional X-ray Market in 2018

General Electric Company:

General Electric Company founded in 1993 and headquartered in Illinois, U.S. The company provides medical imaging, monitoring, gene therapy technologies, bio manufacturing and cell. The company has business segments which are Aviation, Power, Oil & Gas, Healthcare, Renewable Energy, Transportation and Lighting. The company has its subsidiaries and they are Biacore AB (Sweden), Puridify Limited, (U.K.), GE Healthcare BV (Netherland), GE Healthcare Dharmacon, Inc. (U.S.) and many others. The company has its presence in Asia Pacific, Europe, North America, South America and Middle East & Africa.

• In December2018, GE launched its e-learning portal at Lagos Garage Week 2018 in Nigeria. This would help thousands of Nigerians with advanced manufacturing training program.

Access Full Report at: https://databridgemarketresearch.com/reports/global-contrast-and-imaging-agents-in-interventional-x-ray-market/

Bracco Imaging:

Bracco Imaging founded in 1927, headquartered in Milan, Italy. The company provides a variety of products and solutions in diagnostic imaging for all diagnostic modalities. The company has its presence in North America, South America, Europe, Asia Pacific, Middle East & Africa. The company has its subsidiaries and they are Bracco Diagnostics, ACIST Medical Systems, Inc., Spin Spa, Bracco Imaging Holding B.V., Bracco International B.V.

• In May 2018, Shanghai Pharmaceutical Group Co., Ltd. (China) and Bracco Imaging signed a collaboration agreement on the research and development activities in China. This strategy focused on the exploitation of the potentialities of Bracco Imaging microbubbles technology platform for supporting the development of new Shanghai Pharmaceuticals therapeutic products in the oncologic field.

Guerbet:

Guerbet founded in 1926, headquartered in Villepinte, France and is engaged in the manufacturing and offers a wide range of medical solutions and services used in Interventional Imaging and Diagnostic Imaging. The company has it business segment and they are Diagnostic Imaging and Interventional Imaging segment. The company has its presence in Europe, Middle East and Africa, America and Asia-Pacific.

• In July 2018, IBM Watson Health and Guerbet announced a joint agreement for developing an artificial intelligence software solution for supporting liver cancer diagnostics using MRI and CT imaging, and care. This would help the company in expanding their product portfolio.

Market Developments:

• In October 2017, Bracco Imaging acquired SurgVision (Netherlands). This acquisition helped the company to expand its innovative field of fluorescence imaging-guided surgery.
• In July 2018, IBM Watson Health (Massachusetts) and Guerbet announced a joint agreement for developing an artificial intelligence software solution for supporting liver cancer diagnostics using MRI and CT imaging, and care. This would help the company in expanding their product portfolio.
• In April 2018, Guerbet announced the acquisition of a microsphere technology which is developed by Occlugel (France) for strengthening its interventional imaging range.
• In November 2018, Lantheus Holdings announced the presence of Mary Anne Heino who is the President and CEO of the company at the BMO Prescriptions for Success Healthcare Conference on December 12 in New York City.
• In September 2018, Lantheus Holdings announced the presence of Mary Anne Heino who is the President and CEO and Robert Marshall who is the CFO and Treasurer of the company at the 2018 Cantor Fitzgerald Global Healthcare Conference on October 3 in New York City.
• In October 2016, FUJIFILM VisualSonics Inc., received an award of commercial innovation of the year by WMIS. This award was given due to their continuous development of innovative products.